SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Liabilities | ₹2,110 Cr | ₹1,967 Cr | ₹1,576 Cr | ₹1,292 Cr | ₹816 Cr |
What is the latest Total Liabilities ratio of SUVEN PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2023 | ₹2,110 Cr |
Mar2022 | ₹1,967 Cr |
Mar2021 | ₹1,576 Cr |
Mar2020 | ₹1,292 Cr |
Mar2019 | ₹816 Cr |
How is Total Liabilities of SUVEN PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹2,110 Cr | 7.28 | |
Mar2022 | ₹1,967 Cr | 24.78 | |
Mar2021 | ₹1,576 Cr | 21.97 | |
Mar2020 | ₹1,292 Cr | 58.35 | |
Mar2019 | ₹816 Cr | - |
Compare Total Liabilities of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹16,472.6 Cr | 3.4% | -2.3% | 34.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹354,706.0 Cr | -4.9% | -2.6% | 54% | Stock Analytics | |
CIPLA | ₹120,556.0 Cr | -0.1% | 5% | 57.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹118,095.0 Cr | 8.1% | 9.1% | 25.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,162.0 Cr | -2.4% | 10.8% | 110% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,086.0 Cr | 1.4% | -4.8% | 30.2% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | 3.4% |
-2.3% |
34.2% |
SENSEX | 0.4% |
1.1% |
20.6% |
You may also like the below Video Courses